COVID-19-related Ocular Hypertension Secondary to Anterior Uveitis as Part of a Multisystemic Inflammatory Syndrome

J Glaucoma. 2021 May 1;30(5):e256-e258. doi: 10.1097/IJG.0000000000001835.

Abstract

It is the consensus of the medical community that ocular complications associated with Coronavirus Disease 2019 (COVID-19) are mild, self-limiting, and there are no reports to date of a sight-threatening event. We report a patient with a systemic inflammatory syndrome in the context of COVID-19, with ophthalmological (uveitis), dermatological (erythema and skin nodules), and cardiovascular (edema) manifestations. The anterior uveitis led to an increase in the intraocular pressure that failed to respond to clinical treatment and prompted a surgical intervention to save the vision. To the best of our knowledge, this is the first report of a COVID-19-related ocular hypertension. Timely surgical intervention was key to save the vision in the patient's only eye.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • Humans
  • Intraocular Pressure / physiology*
  • Male
  • Middle Aged
  • Ocular Hypertension / etiology*
  • Ocular Hypertension / physiopathology
  • Pandemics
  • SARS-CoV-2
  • Tonometry, Ocular
  • Uveitis, Anterior / complications*